Merck settlement includes ACCME policies agreement

Share this article:
Merck's settlement of Vioxx litigation with 29 states included agreements to abide by ACCME policies regarding disclosure of relationships between speakers and companies and not to fund programs featuring speakers who have spoken at a Merck-sponsored promotional event on a drug in the relevant class within the last 12 months. The settlement commits Merck to these conditions for nine years. 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.